CHILDRENS CANCER AND BLOOD FOUNDATION INC
Mission Statement
The Children's Cancer & Blood Foundation (CCBF), through its support of the Division of Pediatric Hematology and Oncology, has created a standard of excellence in the treatment of children with chronic, life-threatening blood disorders since 1952. We are the oldest and largest charitable organization in the U.S. dedicated to the care of children with cancer and blood disorders. Over the years, CCBF has helped the Division grow into one of the most comprehensive programs of its kind. 1) To support the comprehensive clinical care of children living with cancer and blood disorders 2) To foster research to help understand the causes of childhood cancer and blood disorders 3) To sponsor the fellowship training of pediatricians of the subspecialty of pediatric hematology and oncology
Financial Overview — FY 2024
Compared with Peers
FY 2023| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
82.4% | 84.9% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
13.4% | 11.3% |
P10P90
|
Below median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
4.2% | 0.0% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
46.6 mo | 13.8 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
1.2% | 1.4% |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
66.4% | 94.7% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
-5.2% | 6.3% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-60.9% | 10.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-54.4% | 3.3% |
P10P90
|
Impact
1 program| Outcome / Program | People Served | Cost / Service | # Completed | Duration |
|---|---|---|---|---|
| New treatments for an array of childhood cancers/blood disorders, pts are living longer | 1,000 | $1.00 | — | Lifetime |
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $355K | $1.3M | N/A | — | 1 |
| 2023 | $337K | $520K | $2.0M | 82.4% | 1 |
| 2022 | $355K | $1.3M | $2.0M | 92.3% | 1 |
| 2021 | $599K | $1.0M | N/A | — | 1 |
Donor Reviews
Write a ReviewBe the first to share your experience with this organization.